Clearvision, SoftComply and Comalatech launch compliance management solution MediCompli

The cloud-based solution provides a pre-configured electronic Quality Management System with document approval workflows for the MedTech industry

Southampton, UK: 28th January 2020Clearvision, SoftComply and Comalatech today announced the release of MediCompli – their compliance solution for the Medical Device industry. Based on Atlassian Confluence, this medical device compliance solution includes a pre-configured Quality Management System together with out-of-the-box FDA 21 CFR 11 compliant document approval workflows and e-signatures, all of which fully customisable for additional workflows and compliance requirements.

MediCompli is the result of SoftComply’s industry expertise, Comalatech’s powerful approval workflows and Clearvision’s Atlassian and Cloud experience. Content-wise, users get a Quality Manual, a Quality Policy, 17 SOPs and 50 document templates that are based on ISO 13485, ISO 14971, IEC 62304 and FDA 21 CFR 820. All documents are pre-filled and have embedded guidance to fast-track the development and implementation of their compliant Quality System.

Dr. Marion Lepmets, SoftComply’s co-founder and CEO explains how MediCompli helps companies of all sizes comply with regulation – “With an increasing amount of software in medical devices and with software increasingly in the safety-critical role in these devices, an electronic compliance solution that is fully integrated into the toolset that software developers are already using – the Atlassian stack, is finally available. We are happy to offer MediCompli solution together with Comalatech & Clearvision that will help medical device companies automate their compliance management and get their medical devices on the market faster.”

The pre-defined approval workflows, fully auditable and traceable, are a key part of MediCompli’s Full Audit Trails capability. Comalatech’s CEO, Roberto Dominguez, is excited for the workflows to be available in a solution. “More and more organisations are using our Comala Document Management app to add reviews and approvals in compliance environments. One industry where proper management and control of documentation is crucial is medical device manufacturing. Partnering with Clearvision and SoftComply on MediCompli lets teams utilise approval workflows in a single, complete solution for document compliance.”

Hosting and supporting MediCompli in Clearvision’s AWS-powered cloud service was a natural decision for Gerry Tombs, CEO of the ISO27001 certified Atlassian partner: “Cloud is the way forward for most businesses, especially those that are built on continuous innovation and rapid growth – such as medical devices companies. We are delighted to join SoftComply and Comalatech in helping these fast-paced business focus on what they do best, and freeing them from time consuming compliance processes that are a source of distractions and often end up delaying go-to-market cycles.”

For additional information please visit www.clearvision-cm.com/medicompli/

-ENDS-

SoftComply supports regulated industries around the world in integrating their compliance aspects to Atlassian stack. Medical device companies globally are reducing the time to market for their innovative medical devices by automating their regulatory compliance process – FDA and CE marking, with SoftComply apps on Jira and Confluence. For more information about SoftComply – https://softcomply.com/.

Comalatech is a private Canadian software company dedicated to providing solutions within the Atlassian ecosystem since 2007. Employing staff around the globe, the company is committed to delivering user-friendly products that enhance collaboration in today’s fast-moving workplace. As a supporter of Pledge 1% Comalatech is also proud to give back to the communities it calls home. Learn more about the company and its causes of choice at www.comalatech.com.

Clearvision is an ISO 27001-certified Atlassian Platinum Solution Partner. Experts within the company have helped hundreds of businesses using the Atlassian stack with their consultancy, hosting, training, and support needs.

“Enabling teams to reach their full potential” is the company’s mantra, which is shown through the time and money saved by customers who need not compromise on quality.

Clearvision caters to Atlassian customers, in addition to providing services including ClearHost their trusted hosting platform powered by Amazon Web Services (AWS), and ClearHub a platform for businesses searching for expert Jira, Confluence, and DevOps Contractors, anywhere in the world, with built-in technical support.

From collaborative discovery sessions to ongoing support, Clearvision empower teams to reach their full potential. For more information, please visit www.clearvision-cm.com.

Follow Clearvision on Twitter @clearvisioncm or LinkedIn at https://www.linkedin.com/company/clearvision/ to stay up-to-date with the latest announcements in the Atlassian ecosystem and beyond.

Source: RealWire

user

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

29 minutes ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

30 minutes ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

33 minutes ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

33 minutes ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

33 minutes ago

Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson’s Disease

MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…

33 minutes ago